Languages
Pages
Legal
Explore all categories to find your favorite topic
8/4/2019 Drug-Eluting Stents and Other Anti-Restenosis Devices 1/21842 Rev Esp Cardiol. 2005;58(7):842-62 104Restenosis remains as the main limitation of percuta-neous coronary…
Xiaoxiang Zhu Department of Chemical Engineering Massachusetts Institute of Technology 77 Massachusetts Avenue Room 66-060 Cambridge MA 02139 e-mail: zhuxx@mitedu Richard…
Drug-Eluting Bioabsorbable Stents: Is This the Future of SFA and Popliteal Disease? Lewis B. Schwartz, M.D. Chicago Vascular Specialists Park Ridge, IL …
1 Drug-Eluting Stents For SFA Interventions Ehrin J. Armstrong, MD MSc Director, Interventional Cardiology Director, Vascular Laboratory VA Eastern Colorado Healthcare System…
Drug-Eluting Balloon Angioplasty versus Bare Metal Stents for Femoropopliteal Disease in Real-World Experience Maria Doyle, M.Eng Hilary Coffey, M.D. Ravindra Gullipalli,…
The Detrimental Impact of Chronic Renal Insufficiency James Hermiller, MD, FACC, FSCAI The St Vincent Medical Group The St Vincent Heart Center of Indiana Indianapolis, IN…
Safety of Drug-Eluting Stents in Acute Coronary Syndromes Rotterdam, June 11th 2012 Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials…
c AZOTH Analytics November 2016 Global Coronary Stents Market Bare Metal Drug-Eluting Bioresorable: Analysis By Segment By Region By Country 2016-2021 • By Segment - Bare…
Clinical outcomes after primary PCI using contemporary drug eluting stents: evidence from a network meta-analysis Ply Chichareon MD Carlos Collet Bortone MD Rodrigo Modolo…
Journal Papers 1-44 1. Mäkikallio, Timo et al., Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis NOBLE:…
Available Online through www.ijpbs.com or www.ijpbsonline.com IJPBS Volume 3 Issue 1 JAN-MAR 2013118-130 Review Article Pharmaceutical Sciences International Journal of Pharmacy…
1. A randomised comparison of reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents in patients with diabetes mellitus: the RESERVOIR clinical…
Biolimus A9 Drug-Eluting Stents: Technical Aspects and a Comprehensive Review of the EU, Asia-Pacific, and US Clinical Trial Program Eberhard Grube MD FACC, FSCAI HELIOS…
The recent introduction of drug-eluting stents in interventional cardiology has had a major impact on the treatment of coronary artery disease Online Appendix Online Table…
EVEROLIMUS ELUTING CORONARY STENTS FOR LONG INFRA-POPLITEAL LESIONS FOR CRITICAL LIMB ISCHEMIA: LONG DES-BTK Robert Lookstein MD MHCDL FSIR FAHA FSVM Professor of Radiology…
Bioabsorbable StentsBioabsorbable Stents Ron Waksman, MD, FACC, FSCAIRon Waksman, MD, FACC, FSCAI Professor of Medicine, Georgetown University,Professor of Medicine, Georgetown…
Bioabsorbable Stents The Ideal Scaffold properties and kinetics Jonathan Hill • King’s College Hospital • King’s Health Partners Transient Biodegradable Scaffold…
1. HEART INSTITUTE 2. Prediction of restenosis after PCI withcontemporary drug-eluting stents DR. ASHOK SETHFRCP (LOND), FRCP (EDIN), FRCP (IREL), FACC, FSCAI, FCSI, DSc.CHAIRMAN…
HEART INSTITUTE Prediction of restenosis after PCI with contemporary drug-eluting stents FRCP (LOND), FRCP (EDIN), FRCP (IREL), FACC, FSCAI, FCSI, DSc. DR. ASHOK SETH CHAIRMAN…
DRUG ELUTING STENTS: AN UPDATE WITH A FOCUS ON SAFETY INTRODUCTION The California Technology Assessment Forum has been asked to update the prior assessments of drug-eluting…